# Liberty Global Ltd.: financial statements, quarterly

LBTYA · Nasdaq · CIK 1570585 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lbtya.md) · [Financials](/companies/lbtya/financials.md) · [Filings](/companies/lbtya/filings.md) · [Insiders](/companies/lbtya/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lbtya/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,855](/filings/0001570585-24-000304.md) | [1,024](/filings/0001570585-25-000021.md) | [1,091](/filings/0001570585-25-000114.md) | [1,058](/filings/0001570585-25-000183.md) | [1,070](/filings/0001570585-25-000223.md) | [1,123](/filings/0001570585-25-000021.md) | [1,171](/filings/0001570585-26-000069.md) | [1,269](/filings/0001570585-26-000109.md) | [1,207](/filings/0001570585-25-000223.md) | [1,231 d](/filings/0001570585-26-000014.md) | [1,275](/filings/0001570585-26-000069.md) | [1,172](/filings/0001570585-26-000109.md) |
| Cost of revenue | $m | [586](/filings/0001570585-24-000304.md) | [(455) d](/filings/0001570585-26-000014.md) | [395](/filings/0001570585-25-000114.md) | [336](/filings/0001570585-25-000183.md) | [320](/filings/0001570585-25-000223.md) | [399 d](/filings/0001570585-26-000014.md) | [403](/filings/0001570585-26-000069.md) | [465](/filings/0001570585-26-000109.md) | [393](/filings/0001570585-25-000223.md) | [409 d](/filings/0001570585-26-000014.md) | [427](/filings/0001570585-26-000069.md) | [375](/filings/0001570585-26-000109.md) |
| Selling, general and administrative | $m | [424](/filings/0001570585-24-000304.md) | [(162) d](/filings/0001570585-26-000014.md) | [263](/filings/0001570585-25-000114.md) | [286](/filings/0001570585-25-000183.md) | [270](/filings/0001570585-25-000223.md) | [320 d](/filings/0001570585-26-000014.md) | [285](/filings/0001570585-26-000069.md) | [305](/filings/0001570585-26-000109.md) | [308](/filings/0001570585-25-000223.md) | [330 d](/filings/0001570585-26-000014.md) | [299](/filings/0001570585-26-000069.md) | [312](/filings/0001570585-26-000109.md) |
| Operating income | $m | [(92.8)](/filings/0001570585-25-000021.md) | [(173)](/filings/0001570585-25-000021.md) | [(12.3)](/filings/0001570585-25-000114.md) | [(33.0)](/filings/0001570585-25-000183.md) | [33.4](/filings/0001570585-25-000223.md) | [(48.2)](/filings/0001570585-25-000021.md) | [60.7](/filings/0001570585-26-000069.md) | [29.6](/filings/0001570585-26-000109.md) | [(8.0)](/filings/0001570585-25-000223.md) | [(106) d](/filings/0001570585-26-000014.md) | [23.8](/filings/0001570585-26-000069.md) | [3.0](/filings/0001570585-26-000109.md) |
| Interest expense | $m | [241](/filings/0001570585-23-000417.md) | [252 d](/filings/0001570585-24-000022.md) | [254](/filings/0001570585-24-000136.md) | [144](/filings/0001570585-25-000183.md) | [144](/filings/0001570585-25-000223.md) | [141 d](/filings/0001570585-26-000014.md) | [128](/filings/0001570585-26-000069.md) | [130](/filings/0001570585-26-000109.md) | [123](/filings/0001570585-25-000223.md) | [117 d](/filings/0001570585-26-000014.md) | [114](/filings/0001570585-26-000069.md) | [116](/filings/0001570585-26-000109.md) |
| Income tax | $m | [(1.7)](/filings/0001570585-24-000304.md) | [43.1 d](/filings/0001570585-26-000014.md) | [42.8](/filings/0001570585-25-000114.md) | [28.2](/filings/0001570585-25-000183.md) | [(11.2)](/filings/0001570585-25-000223.md) | [(90.6) d](/filings/0001570585-26-000014.md) | [(70.0)](/filings/0001570585-26-000069.md) | [0.9](/filings/0001570585-26-000109.md) | [(46.9)](/filings/0001570585-25-000223.md) | [40.2 d](/filings/0001570585-26-000014.md) | [175](/filings/0001570585-26-000069.md) | [22.8](/filings/0001570585-26-000109.md) |
| Net income | $m | [659](/filings/0001570585-25-000021.md) | [(3,490)](/filings/0001570585-25-000021.md) | [510](/filings/0001570585-25-000114.md) | [268](/filings/0001570585-25-000183.md) | [(1,434)](/filings/0001570585-25-000223.md) | [2,244](/filings/0001570585-25-000021.md) | [(1,337)](/filings/0001570585-26-000069.md) | [(2,793)](/filings/0001570585-26-000109.md) | [(90.7)](/filings/0001570585-25-000223.md) | [(2,917) d](/filings/0001570585-26-000014.md) | [338](/filings/0001570585-26-000069.md) | [(365)](/filings/0001570585-26-000109.md) |
| Diluted EPS | $ per share | [1.57](/filings/0001570585-25-000021.md) | [(8.92)](/filings/0001570585-25-000021.md) | [1.32](/filings/0001570585-25-000114.md) | [0.71](/filings/0001570585-25-000183.md) | [(3.95)](/filings/0001570585-25-000223.md) | [6.11](/filings/0001570585-25-000021.md) | [(3.84)](/filings/0001570585-26-000069.md) | [(8.09)](/filings/0001570585-25-000183.md) | [(0.27)](/filings/0001570585-25-000223.md) | not reported | [0.96](/filings/0001570585-26-000069.md) | not reported |
| Basic EPS | $ per share | [1.58](/filings/0001570585-25-000021.md) | [(8.92)](/filings/0001570585-25-000021.md) | [1.35](/filings/0001570585-25-000114.md) | [0.72](/filings/0001570585-25-000183.md) | [(3.95)](/filings/0001570585-25-000223.md) | [6.32](/filings/0001570585-25-000021.md) | [(3.84)](/filings/0001570585-26-000069.md) | [(8.09)](/filings/0001570585-26-000109.md) | [(0.27)](/filings/0001570585-25-000223.md) | not reported | [1.01](/filings/0001570585-26-000069.md) | [(1.07)](/filings/0001570585-26-000109.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.7](/filings/0001570585-24-000304.md) | [1.4](/filings/0001570585-26-000014.md) | [1.1](/filings/0001570585-25-000114.md) | [2.0](/filings/0001570585-25-000183.md) | [2.3](/filings/0001570585-25-000223.md) | [1.8](/filings/0001570585-26-000014.md) | [2.0](/filings/0001570585-26-000069.md) | [1.8](/filings/0001570585-26-000109.md) | [1.7](/filings/0001570585-25-000223.md) | [2.1](/filings/0001570585-26-000109.md) | [1.8](/filings/0001570585-26-000069.md) | [2.4](/filings/0001570585-26-000109.md) |
| Current assets | $bn | [5.4](/filings/0001570585-23-000417.md) | [5.6](/filings/0001570585-25-000021.md) | [4.9](/filings/0001570585-24-000136.md) | [5.4](/filings/0001570585-24-000237.md) | [5.2](/filings/0001570585-24-000304.md) | [3.3](/filings/0001570585-26-000014.md) | [3.1](/filings/0001570585-25-000114.md) | [4.4](/filings/0001570585-25-000183.md) | [2.8](/filings/0001570585-25-000223.md) | [3.4](/filings/0001570585-26-000109.md) | [3.1](/filings/0001570585-26-000069.md) | [3.5](/filings/0001570585-26-000109.md) |
| Total assets | $bn | [42.7](/filings/0001570585-23-000417.md) | [42.1](/filings/0001570585-25-000021.md) | [40.6](/filings/0001570585-24-000136.md) | [40.8](/filings/0001570585-24-000237.md) | [41.8](/filings/0001570585-24-000304.md) | [25.4](/filings/0001570585-26-000014.md) | [26.0](/filings/0001570585-25-000114.md) | [27.2](/filings/0001570585-25-000183.md) | [25.4](/filings/0001570585-25-000223.md) | [22.6](/filings/0001570585-26-000109.md) | [21.9](/filings/0001570585-26-000069.md) | [21.5](/filings/0001570585-26-000109.md) |
| Current liabilities | $bn | [3.7](/filings/0001570585-23-000417.md) | [4.3](/filings/0001570585-25-000021.md) | [3.8](/filings/0001570585-24-000136.md) | [4.0](/filings/0001570585-24-000237.md) | [4.4](/filings/0001570585-24-000304.md) | [3.1](/filings/0001570585-26-000014.md) | [3.3](/filings/0001570585-25-000114.md) | [4.3](/filings/0001570585-25-000183.md) | [2.9](/filings/0001570585-25-000223.md) | [3.2](/filings/0001570585-26-000109.md) | [2.8](/filings/0001570585-26-000069.md) | [2.7](/filings/0001570585-26-000109.md) |
| Total liabilities | $bn | [21.8](/filings/0001570585-23-000417.md) | [23.1](/filings/0001570585-25-000021.md) | [22.2](/filings/0001570585-24-000136.md) | [22.5](/filings/0001570585-24-000237.md) | [23.1](/filings/0001570585-24-000304.md) | [12.9](/filings/0001570585-26-000014.md) | [13.1](/filings/0001570585-25-000114.md) | [14.0](/filings/0001570585-25-000183.md) | [12.4](/filings/0001570585-25-000223.md) | [12.7](/filings/0001570585-26-000109.md) | [12.1](/filings/0001570585-26-000069.md) | [12.1](/filings/0001570585-26-000109.md) |
| Long-term debt | $bn | [14.5](/filings/0001570585-23-000417.md) | [14.9](/filings/0001570585-24-000022.md) | [14.7](/filings/0001570585-24-000136.md) | [14.7](/filings/0001570585-24-000237.md) | [14.8](/filings/0001570585-24-000304.md) | [8.2](/filings/0001570585-25-000021.md) | [8.2](/filings/0001570585-25-000114.md) | [7.8](/filings/0001570585-25-000183.md) | [7.8](/filings/0001570585-25-000223.md) | [7.8](/filings/0001570585-26-000014.md) | [7.7](/filings/0001570585-26-000069.md) | [7.7](/filings/0001570585-26-000109.md) |
| Current portion of debt | $bn | [0.6](/filings/0001570585-23-000417.md) | [0.8](/filings/0001570585-24-000022.md) | [0.7](/filings/0001570585-24-000136.md) | [0.8](/filings/0001570585-24-000237.md) | [1.0](/filings/0001570585-24-000304.md) | [0.9](/filings/0001570585-25-000021.md) | [1.1](/filings/0001570585-25-000114.md) | [2.0](/filings/0001570585-25-000183.md) | [0.7](/filings/0001570585-25-000223.md) | [0.8](/filings/0001570585-26-000014.md) | [0.7](/filings/0001570585-26-000069.md) | [0.6](/filings/0001570585-26-000109.md) |
| Shareholders' equity | $bn | [20.9](/filings/0001570585-23-000417.md) | [19.1](/filings/0001570585-25-000021.md) | [18.4](/filings/0001570585-24-000136.md) | [18.3](/filings/0001570585-24-000237.md) | [18.7](/filings/0001570585-24-000304.md) | [12.4](/filings/0001570585-26-000014.md) | [12.6](/filings/0001570585-25-000114.md) | [13.0](/filings/0001570585-25-000183.md) | [12.7](/filings/0001570585-25-000223.md) | [9.7](/filings/0001570585-26-000109.md) | [9.5](/filings/0001570585-26-000069.md) | [9.2](/filings/0001570585-26-000109.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [327 d](/filings/0001570585-24-000304.md) | [839 d](/filings/0001570585-26-000014.md) | [246](/filings/0001570585-25-000114.md) | [546 d](/filings/0001570585-25-000183.md) | [450 d](/filings/0001570585-25-000223.md) | [792 d](/filings/0001570585-26-000014.md) | [129](/filings/0001570585-26-000069.md) | [149 d](/filings/0001570585-26-000109.md) | [302 d](/filings/0001570585-25-000223.md) | [631 d](/filings/0001570585-26-000014.md) | [108](/filings/0001570585-26-000069.md) | [231 d](/filings/0001570585-26-000109.md) |
| Capital expenditure | $m | [328 d](/filings/0001570585-24-000304.md) | [(94.3) d](/filings/0001570585-26-000014.md) | [206](/filings/0001570585-25-000114.md) | [185 d](/filings/0001570585-25-000183.md) | [221 d](/filings/0001570585-25-000223.md) | [297 d](/filings/0001570585-26-000014.md) | [243](/filings/0001570585-26-000069.md) | [319 d](/filings/0001570585-26-000109.md) | [343 d](/filings/0001570585-25-000223.md) | [438 d](/filings/0001570585-26-000014.md) | [398](/filings/0001570585-26-000069.md) | [348 d](/filings/0001570585-26-000109.md) |
| Share repurchases | $m | [525 d](/filings/0001570585-24-000304.md) | [362 d](/filings/0001570585-26-000014.md) | [176](/filings/0001570585-25-000114.md) | [170 d](/filings/0001570585-25-000183.md) | [165 d](/filings/0001570585-25-000223.md) | [178 d](/filings/0001570585-26-000014.md) | [37.9](/filings/0001570585-26-000069.md) | [64.1 d](/filings/0001570585-26-000109.md) | [56.2 d](/filings/0001570585-25-000223.md) | [33.9 d](/filings/0001570585-26-000014.md) | [0.0](/filings/0001570585-26-000069.md) | [0.0 d](/filings/0001570585-26-000109.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [509](/filings/0001570585-23-000351.md) | [483](/filings/0001570585-23-000417.md) | [454](/filings/0001570585-24-000136.md) | [442](/filings/0001570585-24-000237.md) | [421](/filings/0001570585-24-000304.md) | [385](/filings/0001570585-25-000114.md) | [377](/filings/0001570585-25-000183.md) | [363](/filings/0001570585-25-000223.md) | [348](/filings/0001570585-26-000069.md) | [345](/filings/0001570585-25-000183.md) | [340](/filings/0001570585-25-000223.md) | [351](/filings/0001570585-26-000069.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.